Acta Paediatrica · 1971 · 11 citations · 8 references
PharmacyPharmacologyToxicologyHeavy Metal ToxicologyPediatric Clinical PharmacologyPharmaceutical ToxicologyChelation TherapyLead ExposureLead PoisoningLead ToxicologyPediatric Heavy Metal PoisoningPediatric Poisoning ManagementBlood Heavy Metal LevelsChelator SafetyChildhood Lead ExposurePediatric Lead ChelationPediatric Lead PoisoningPediatric Lead Toxicity
Summary Oral D‐penicillamine and intramuscular BAL + EDTA have been used in the treatment of lead accumulation in three children with blood levels of at least 70 µUg per 100 ml. Lead balance studies were done during control periods and while the children were given either D‐penicillamine orally or BAL plus EDTA intramuscularly. There was a marked cumulative negative lead balance and the blood lead levels decreased to normal after 6 days with either treatment. The results indicate that D‐penicillamine given to three children orally, in doses as high as 100 mg/kg/day, is an effective and non‐toxic lead chelator for short‐term use.
8
The pharmacological basis of therapeutics
American Heart Journal · 1966 · 292 citations · Full text
Alan Moncrieff, O. P. Koumides, B. E. Clayton et al. · Archives of Disease in Childhood · 1964 · 250 citations · Full text
Pharmacy, Pediatrics, Toxicology +11
Treatment of Lead-poisoning with Oral Penicillamine
A. Goldberg, Jacqueline A.M. Smith, A. C. Lochhead · BMJ · 1963 · 99 citations · Full text
Treatment of lead encephalopathy in children
Roberta Coffin, Jerri Linn Phillips, William I. Staples et al. · The Journal of Pediatrics · 1966 · 50 citations
Medicine, Neurology, Pediatrics +8